跳至主要内容
临床试验/KCT0007983
KCT0007983尚未招募未知

Multicenter, randomized, open clinical study to evaluate efficacy and safety of Calcineurin inhibitors versus Mycophenolate in pediatric steroid-resistant nephrotic syndrome

Seoul National University Hospital0 个研究点目标入组 140 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
2(Year) 至 15(Year)(—)
性别
All

入选标准

  • More than 2 years old and under the 16 years old,
  • From Cohort of Korean pediatric nephrotic syndrome
  • Patients who did not get the remission, by steroid (for initial 4 weeks) and CNI (for next 3 months)

排除标准

  • - Patients who were used secondary immunosuppressants (CPM, MMF, RTX, levamisole, mizoribin) for nephrotic syndrome within 4 weeks
  • - Secondary nephrotic syndrome
  • - Low C3 (< 60mg/dL)
  • - Patients who confirmed as genetic mutation associated with proteinuria or nephrotic syndrome

研究者

相似试验

Multicenter, randomized, open clinical study to... | 临床试验